Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VUDALIMAB: 66 Adverse Event Reports & Safety Profile

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More
66
Total FAERS Reports
17 (25.8%)
Deaths Reported
51
Hospitalizations
66
As Primary/Secondary Suspect
10
Life-Threatening

First Report: 20180101 · Latest Report: 20250716

What Are the Most Common VUDALIMAB Side Effects?

#1 Most Reported
Anaemia
21 reports (31.8%)
#2 Most Reported
C-reactive protein increased
20 reports (30.3%)
#3 Most Reported
Pyrexia
18 reports (27.3%)

All VUDALIMAB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Anaemia 21 31.8% 3 19
C-reactive protein increased 20 30.3% 7 20
Pyrexia 18 27.3% 0 16
Malignant neoplasm progression 13 19.7% 5 11
Pneumonia 13 19.7% 2 13
Dyspnoea 12 18.2% 1 11
Nausea 12 18.2% 6 11
Platelet count decreased 12 18.2% 1 10
Hypoxia 10 15.2% 2 10
Vomiting 10 15.2% 0 10
Abdominal pain 9 13.6% 7 9
Asthenia 9 13.6% 0 8
Fatigue 9 13.6% 1 6
Hypotension 9 13.6% 1 9
Blood creatinine increased 8 12.1% 0 8
Chromaturia 8 12.1% 0 8
Infusion related reaction 8 12.1% 0 7
Abdominal distension 7 10.6% 7 7
Abdominal pain lower 7 10.6% 0 7
Ascites 7 10.6% 0 1

Who Reports VUDALIMAB Side Effects? Age & Gender Data

Gender: 26.0% female, 74.0% male. Average age: 66.2 years. Most reports from: ES. View detailed demographics →

Is VUDALIMAB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2018 1 0 0
2023 12 4 11
2024 40 9 33
2025 8 4 4

View full timeline →

What Is VUDALIMAB Used For?

IndicationReports
Non-small cell lung cancer 37
Adenocarcinoma 18
Prostate cancer 5

Official FDA Label for VUDALIMAB

Official prescribing information from the FDA-approved drug label.